Optimal Acuity Corporation

Untitled design (8)

STAY INFORMED ON THE LATEST DEVELOPMENTS FROM OPTIMAL ACUITY CORPORATION

The Clear-K® Treatment is being studied for the treatment of dry and wet AMD and other ocular diseases and disorders and is not approved for sale in the United States.  CAUTION Investigational device. Limited by Federal (or the United States) law to investigational use. If you would like to receive updates about clinical studies for the Clear-K® Treatment, Please complete the form below: